Avantor (AVTR) Cash from Investing Activities (2018 - 2026)
Avantor (AVTR) recorded quarterly Cash from Investing Activities of -$32.7 million in Q1 2026, up 17.63% quarter-over-quarter from -$39.7 million in Q4 2025, and down 13.15% on a YoY basis from -$37.7 million in Q1 2025.
Avantor (AVTR) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Avantor's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$32.7 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 13.15% year-over-year to -$32.7 million; the TTM figure through Mar 2026 stood at -$134.3 million (down 130.23% YoY), while the FY2025 annual figure was -$130.5 million, down 129.73% from the prior year.
- Cash from Investing Activities was -$32.7 million for Q1 2026 at Avantor, up from -$39.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $558.5 million in Q4 2024 to a low of -$50.0 million in Q4 2023.
- Historically, Cash from Investing Activities has averaged $1.3 million across 5 years, with a median of -$33.3 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities sank 1002.44% in 2023, then jumped 1217.0% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$33.1 million in 2022, then slumped by 51.06% to -$50.0 million in 2023, then surged by 1217.0% to $558.5 million in 2024, then plunged by 107.11% to -$39.7 million in 2025, then grew by 17.63% to -$32.7 million in 2026.
- The last three Cash from Investing Activities figures came in at -$32.7 million (Q1 2026), -$39.7 million (Q4 2025), and -$33.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | -32.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.70 Mn |
| Mar 31, 2026 | -32.70 Mn |
| Dec 31, 2025 | -39.70 Mn |
| Dec 31, 2025 | -39.70 Mn |
| Sep 30, 2025 | -33.30 Mn |
| Sep 30, 2025 | -33.30 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Mar 31, 2025 | -28.90 Mn |
| Mar 31, 2025 | -28.90 Mn |
| Dec 31, 2024 | 558.50 Mn |
| Dec 31, 2024 | 558.50 Mn |
| Sep 30, 2024 | -40.50 Mn |
| Sep 30, 2024 | -40.50 Mn |
| Jun 30, 2024 | -44.90 Mn |
| Jun 30, 2024 | -44.90 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Dec 31, 2023 | -50.00 Mn |
| Dec 31, 2023 | -50.00 Mn |